Fenobam

DB12931InvestigationalSmall molecule

Fenobam is under investigation in clinical trial NCT00637221 (Open Label Study Investigating Safety and Efficacy of Fenobam anhydrous 50 mg - 150 mg on Prepulse Inhibition Tests and Continuous Performance...

Formula / weight: C₁₁H₁₁ClN₄O₂ · 266.69 g/mol (avg)
Code names: NPL-2009

Resolves to

Compound

UNII078RCY7I27CAS57653-26-6ChEMBLCHEMBL239800ChEBI92728PubChem162834

Structure

InChIKeyDWPQODZAOSWNHB-UHFFFAOYSA-NSMILESCN1CC(=O)N=C1NC(=O)NC1=CC=CC(Cl)=C1

Targets

P41594GRM5

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Fenobam, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account